Advertisement
Singapore markets close in 5 hours 42 minutes
  • Straits Times Index

    3,276.45
    -11.30 (-0.34%)
     
  • Nikkei

    37,780.35
    +151.87 (+0.40%)
     
  • Hang Seng

    17,596.43
    +311.89 (+1.80%)
     
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • Bitcoin USD

    64,409.65
    +127.74 (+0.20%)
     
  • CMC Crypto 200

    1,392.04
    +9.47 (+0.68%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,346.70
    +4.20 (+0.18%)
     
  • Crude Oil

    83.83
    +0.26 (+0.31%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,572.86
    +3.61 (+0.23%)
     
  • Jakarta Composite Index

    7,116.58
    -38.71 (-0.54%)
     
  • PSE Index

    6,550.37
    -24.51 (-0.37%)
     

How Puma Biotechnology Performed in Q2 2018

How Puma Biotechnology Performed in Q2 2018

Puma Biotechnology (PBYI) released its second-quarter earnings results on August 9. It reported net revenue of $117.3 million in the first half of 2018. Puma Biotechnology’s revenue came primarily from its sales of Nerlynx.